Evolution Global Acquisition CORP (EVOXU) — SEC Filings

Overview

Evolution Global Acquisition CORP (EVOXU) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Dec 16, 2025: Evolution Global Acquisition Corp (EVOXU), a blank check company, reported a net loss of $72,700 for the three months ended September 30, 2025, and a cumulative net loss of $93,518 from its inception on June 26, 2025, through September 30, 2025. The company had no operating revenues during this peri

Sentiment Summary

Across 9 filings, the sentiment breakdown is: 1 bearish, 6 neutral, 2 mixed. The dominant filing sentiment for Evolution Global Acquisition CORP is neutral.

Filing Type Overview

Evolution Global Acquisition CORP (EVOXU) has filed 1 10-Q, 4 8-K, 3 S-1/A, 1 S-1 with the SEC between Jul 2025 to Dec 2025.

Recent Filings (9)

• EVOXU Reports Q3 Loss, Closes $240M IPO Post-Quarter — 10-Q · Dec 16, 2025 Risk: medium
  Evolution Global Acquisition Corp (EVOXU), a blank check company, reported a net loss of $72,700 for the three months ended September 30, 2025, and a cumulative
• Evolution Global Acquisition Corp. Announces Board and Officer Changes — 8-K · Dec 3, 2025 Risk: medium
  Evolution Global Acquisition Corp. announced on December 2, 2025, changes in its board of directors and officer appointments. Specifically, the company reported
• 8-K Filing — 8-K · Dec 1, 2025
• 8-K Filing — 8-K · Nov 18, 2025
• 8-K Filing — 8-K · Nov 13, 2025
• EVOXU Targets $175M IPO for Critical Minerals SPAC — S-1/A · Oct 22, 2025 Risk: high
  Evolution Global Acquisition Corp (EVOXU) filed an S-1/A on October 22, 2025, for an initial public offering of 17,500,000 units at $10.00 per unit, aiming to r
• EVOXU Targets Critical Minerals with $175M IPO, SPAC Eyes 24-Month Deal — S-1/A · Oct 1, 2025 Risk: high
  Evolution Global Acquisition Corp (EVOXU) filed an S-1/A on October 1, 2025, for an initial public offering of 17,500,000 units at $10.00 per unit, aiming to ra
• EVOXU Files S-1/A for $175M IPO Targeting Critical Minerals SPAC — S-1/A · Sep 9, 2025 Risk: high
  Evolution Global Acquisition Corp (EVOXU) filed an S-1/A on September 8, 2025, for an initial public offering of 17,500,000 units at $10.00 per unit, aiming to
• Evolution Global Files S-1, Signaling SPAC IPO Intent — S-1 · Jul 31, 2025 Risk: high
  Evolution Global Acquisition Corp (EVOXU) filed an S-1 on July 31, 2025, to register securities for a proposed public offering, indicating its intent to become

Risk Profile

Risk Assessment: Of EVOXU's 6 recent filings, 4 were flagged as high-risk, 2 as medium-risk, and 0 as low-risk. The overall risk profile suggests elevated risk that warrants close monitoring.

Financial Highlights

Key financial metrics from Evolution Global Acquisition CORP's most recent 10-Q filing (Dec 16, 2025):

• Revenue: $0
• Net Income: -$72,700
• EPS: -$0.01
• Debt-to-Equity: N/A
• Cash Position: N/A
• Operating Margin: N/A
• Total Assets: $264,878
• Total Debt: $241,107

Key Executives

• Stephen Silver
• Mitchell S. Nussbaum
• Alan I. Annex
• Ashley Zumwalt-Forbes
• Arthur Chen
• David Levine
• Julia Aryeh
• Jason T. Simon

Industry Context

Evolution Global Acquisition Corp operates within the Special Purpose Acquisition Company (SPAC) sector. This sector has seen significant growth and subsequent volatility, with increasing regulatory scrutiny. SPACs are essentially shell companies that go public to raise capital for the purpose of acquiring an existing private company, thereby taking it public. The competitive landscape involves numerous SPACs vying to identify and merge with attractive targets within a limited timeframe.

Top Tags

SPAC (5) · Blank Check Company (5) · Critical Minerals (3) · IPO (3) · Emerging Growth Company (3) · Dilution Risk (2) · Nasdaq Listing (2) · Initial Public Offering (1) · Q3 2025 Earnings (1) · Financial Condition (1)

Key Numbers

• Accumulated Deficit: $93,518 — Net loss from inception (June 26, 2025) through September 30, 2025
• IPO Gross Proceeds: $240,000,000 — Amount raised from the Initial Public Offering on November 12, 2025, including over-allotment
• Private Placement Warrants Proceeds: $6,800,000 — Amount raised from the sale of Private Placement Warrants on November 12, 2025
• Total Transaction Costs: $15,036,813 — Costs associated with the Initial Public Offering
• Class A Ordinary Shares Outstanding: 24,000,000 — Number of shares issued in the IPO as of December 16, 2025
• Class B Ordinary Shares Outstanding: 8,000,000 — Number of Founder Shares issued and outstanding as of December 16, 2025
• Completion Window: 24 months — Timeframe from IPO closing to complete a Business Combination
• Promissory Note - Related Party: $241,107 — Outstanding balance as of September 30, 2025, repaid on November 12, 2025
• Total Public Offering Price: $175,000,000 — Amount to be raised from the IPO of 17,500,000 units at $10.00 each.
• Per Unit Offering Price: $10.00 — The price at which each unit is offered to the public.
• Underwriting Discounts and Commissions: $10,500,000 — Total fees for underwriters, including $7,000,000 deferred.
• Class B Ordinary Shares: 6,666,667 — Number of founder shares held by the sponsor and management.
• Per Share Purchase Price (Class B): $0.004 — The price paid by the sponsor for Class B ordinary shares, indicating significant dilution for public shareholders.
• Private Placement Warrants: 5,500,000 — Number of warrants to be purchased by the sponsor and underwriters.
• Per Warrant Purchase Price (Private Placement): $1.00 — The price paid for each private placement warrant.

Related Companies

EVOX · EVOXW

Frequently Asked Questions